All PlansAdministrativeLow impact
Tips to improve Follow-Up Care for Children Prescribed ADHD Medication (ADD-E)
Cigna·Pediatrics, Family Medicine, Psychiatry·Pharmacy
Effective date
Nov 18, 2025
We identified it
Jun 18, 2026
Summary
This policy provides guidance on improving follow-up care for children aged 6-12 prescribed ADHD medication to meet HEDIS ADD-E quality measures. It outlines best practices for scheduling follow-up visits within 30 days of medication initiation and maintaining care over 9 months, but does not introduce new billing requirements or code changes.
Action Required
No immediate billing changes required. Providers should review HEDIS ADD-E measure requirements and implement suggested practices: proactively schedule follow-up appointments within 30 days of ADHD medication initiation, ensure at least two follow-up visits within 9 months, and document all care appropriately to support quality reporting.